Kun Yu

发表

Conservation of Breast Cancer Molecular Subtypes and Transcriptional Patterns of Tumor Progression Across Distinct Ethnic Populations

Puay Hoon Tan, P. Tan, Kun Yu, 2004, Clinical Cancer Research.

A Modular Analysis of Breast Cancer Reveals a Novel Low-Grade Molecular Signature in Estrogen Receptor–Positive Tumors

Lance D. Miller, L. Miller, Kun Yu, 2006, Clinical Cancer Research.

Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes

Jason G. Jin, M. Ayers, I. Sohn, 2015, Nature Medicine.

A combined comparative genomic hybridization and expression microarray analysis of gastric cancer reveals novel molecular subtypes.

Siew Hong Leong, Oi Lian Kon, Soo Yong Tan, 2003, Cancer research.

A Precisely Regulated Gene Expression Cassette Potently Modulates Metastasis and Survival in Multiple Solid Cancers

Hongmin Li, Shing Chuan Hooi, X. Zhao, 2008, PLoS genetics.

Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma.

M. Salto‐Tellez, P. Tan, H. Huynh, 2008, Journal of hepatology.

Molecular-assisted immunohistochemical optimization.

M. Salto‐Tellez, T. Putti, Kun Yu, 2010, Acta histochemica.

Nomogram for Prediction of Hepatocellular Carcinoma Prognosis

Lei Wu, Kun Yu, Yongsheng Li, 2021, Current Bioinformatics.

Cancer Risk and Mutational Patterns Following Organ Transplantation

Kun Yu, C. Feng, Yuefeng Gao, 2022, Frontiers in Cell and Developmental Biology.

FGF19/SOCE/NFATc2 signaling circuit facilitates the self-renewal of liver cancer stem cells

Lei Wu, Kun Yu, Yongsheng Li, 2021, Theranostics.

Quantitative profiling of drug-associated proteomic alterations by combined 2-nitrobenzenesulfenyl chloride (NBS) isotope labeling and 2DE/MS identification.

Kun Yu, P. Tan, Ei-ichi Matsuo, 2006, Journal of proteome research.

Whole-genome sequencing of asian lung cancers: second-hand smoke unlikely to be responsible for higher incidence of lung cancer among Asian never-smokers.

B. Peters, Geoffrey B. Nilsen, P. Ng, 2014, Cancer research.

CD68- and CD163-positive tumor infiltrating macrophages in non-metastatic breast cancer: a retrospective study and meta-analysis

Kun Yu, C. Ni, Qiuran Xu, 2019, Journal of Cancer.

CDKN1C (p57KIP2) Is a Direct Target of EZH2 and Suppressed by Multiple Epigenetic Mechanisms in Breast Cancer Cells

L. Miller, Qiang Yu, Kun Yu, 2009, PloS one.

Global Map of Growth-Regulated Gene Expression in Burkholderia pseudomallei, the Causative Agent of Melioidosis

Richard W. Titball, Wei Chen, Chi Ho Lin, 2006, Journal of bacteriology.

Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations.

R. Berger, M. Galsky, D. Bajorin, 2018, Cancer discovery.

Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes

Derek Y. Chiang, S. Jaeger, Y. Huang, 2017, Molecular Cancer Research.

Hsa_circ_0046264 up-regulated BRCA2 to suppress lung cancer through targeting hsa-miR-1245

Kun Yu, Xiaosan Su, B. Jiao, 2018, Respiratory Research.

SPRY4 suppresses proliferation and induces apoptosis of colorectal cancer cells by repressing oncogene EZH2

Kun Yu, Qiang Li, Jia Guo, 2021, Aging.

Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target gene.

H. Grabsch, B. Ylstra, G. Meijer, 2008, Cancer research.

H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma.

M. Hao, M. Warmuth, V. Subramanian, 2017, Cancer research.

A molecular signature of the Nottingham prognostic index in breast cancer.

Puay Hoon Tan, P. Tan, Kun Yu, 2004, Cancer research.

MiR-17 Regulates Prostate Cancer Cell Proliferation and Apoptosis Through Inhibiting JAK-STAT3 Signaling Pathway.

Kun Yu, Hong Dai, Chunmei Wang, 2018, Cancer biotherapy & radiopharmaceuticals.

Clinical Validation of a Customized Multiple Signature Microarray for Breast Cancer

P. Tan, K. Soo, H. Koong, 2008, Clinical Cancer Research.

Genomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencing

Jason G. Jin, Joon-Oh Park, H. Dai, 2014, Nature Communications.

Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.

Keli Ou, Manuel Salto-Tellez, Osamu Nishimura, 2008, Journal of proteome research.

An Observational Study on the Molecular Profiling of Primary Melanomas Reveals a Progression Dependence on Mitochondrial Activation

J. Malm, Kun Yu, G. Marko‐Varga, 2021, Cancers.

An Alternative Approach to Determining Therapeutic Choices in Advanced Non-small Cell Lung Carcinoma (NSCLC): Maximizing the Diagnostic Procedure and the Use of Low-Volume Lung Biopsies

Kun Yu, P. Tan, E. Lim, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Deep decision support for lymph node metastatic risk evaluation

Kun Yu, Eliana Marostica, 2020, EBioMedicine.

Clinical Validation of a Customized Multiple Signature Microarray for Breast Cancer

P. Tan, K. Soo, H. Koong, 2008, Clinical Cancer Research.

Whole-genome sequencing of asian lung cancers: second-hand smoke unlikely to be responsible for higher incidence of lung cancer among Asian never-smokers.

B. Peters, Geoffrey B. Nilsen, P. Ng, 2014, Cancer research.

Conservation of Breast Cancer Molecular Subtypes and Transcriptional Patterns of Tumor Progression Across Distinct Ethnic Populations

P. Tan, Kun Yu, Chee-How Lee, 2004, Clinical Cancer Research.